Aurora Spine Corp (TSE:ASG)
:ASG
Want to see TSE:ASG full AI Analyst Report?
ASG Stock Chart & Stats
C$0.28
>-C$0.01(-1.05%)
At close: 4:00 PM EST
C$0.28
>-C$0.01(-1.05%)
Day’s Range― - ―
52-Week RangeC$0.22 - C$0.36
Previous CloseN/A
Volume6.50K
Average Volume (3M)30.19K
Market Cap
C$18.73M
Enterprise ValueC$13.70M
Total Cash (Recent Filing)C$895.08K
Total Debt (Recent Filing)C$689.12K
Price to Earnings (P/E)―
Beta0.21
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding78,054,950
10 Day Avg. Volume38,837
30 Day Avg. Volume30,190
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)4.02
Price to Sales (P/S)0.82
P/FCF Ratio36.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Cash GenerationThe shift to positive operating cash flow ($1.06M TTM) and positive free cash flow ($0.44M TTM) is a durable improvement in internal funding. Over months this reduces reliance on external financing, supports working capital and targeted investment, and increases resilience while profitability stabilizes.
Reduced LeverageA materially lower debt load and debt-to-equity below 1x improve financial flexibility and lower interest burden. This structural deleveraging reduces refinancing risk and gives management room to allocate cash to growth or R&D over the coming months without meaningful covenant pressure.
Revenue Growth And Gross MarginSustained revenue growth coupled with a high gross margin (~60%) indicates scalable product economics and pricing power. If maintained, this durable mix can drive operating leverage over 2–6 months, improving the odds of converting top-line gains into operating profitability.
Bears Say
Continued Net LossesPersistent net losses and slightly negative EBIT mean the company has not yet converted revenue growth into sustainable profitability. Over the medium term this can erode equity, necessitate further financing, and constrain investment in commercialization or R&D until operating income turns definitively positive.
Negative Return On EquityA materially negative ROE (~-33% TTM) signals that deployed capital is not producing shareholder returns. Structurally, until ROE moves into positive territory, the company will struggle to demonstrate efficient capital allocation and attract stable long-term capital without improvements in profit generation.
Volatile Free Cash Flow GrowthAlthough FCF is currently positive, the extremely negative FCF growth rate (-830% TTM) points to volatility in cash conversion. This structural inconsistency raises the risk that cash generation may reverse, leaving the company exposed to liquidity needs or dilution if positive FCF cannot be sustained.
Aurora Spine News
ASG FAQ
What was Aurora Spine Corp’s price range in the past 12 months?
Aurora Spine Corp lowest stock price was C$0.21 and its highest was C$0.35 in the past 12 months.
What is Aurora Spine Corp’s market cap?
Aurora Spine Corp’s market cap is C$18.73M.
When is Aurora Spine Corp’s upcoming earnings report date?
Aurora Spine Corp’s upcoming earnings report date is May 27, 2026 which is in 6 days.
How were Aurora Spine Corp’s earnings last quarter?
Currently, no data Available
Is Aurora Spine Corp overvalued?
According to Wall Street analysts Aurora Spine Corp’s price is currently Overvalued.
Does Aurora Spine Corp pay dividends?
Aurora Spine Corp does not currently pay dividends.
What is Aurora Spine Corp’s EPS estimate?
Aurora Spine Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aurora Spine Corp have?
Aurora Spine Corp has 78,054,950 shares outstanding.
What happened to Aurora Spine Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aurora Spine Corp?
Currently, no hedge funds are holding shares in TSE:ASG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aurora Spine Corp
Aurora Spine (ASG) is a medical device company focused on developing innovative spinal implants and surgical solutions. The company operates in the orthopedic and spinal surgery sectors, providing a range of products that include interbody fusion devices, spinal fixation systems, and minimally invasive surgical tools. Aurora Spine aims to improve patient outcomes and enhance surgical efficiency through its advanced technology and commitment to research and development.
Technical Analysis
Perimeter Medical Imaging AI
―
―
Theralase Technologies
―
VentriPoint Diagnostics
―
―
Options Prices
Currently, No data available
---